Knockdown of Rap2B, a Ras Superfamily Protein, Inhibits Proliferation, Migration, and Invasion in Cervical Cancer Cells via Regulating the ERK1/2 Signaling Pathway

Author:

Li Yinghua1,Li Songyi2,Huang Lili1

Affiliation:

1. Department of Gynecology and Obstetrics, Women’s Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, P.R. China

2. Department of Gynecology and Obstetrics, Women’s Hospital of Hangzhou City, Hangzhou, P.R. China

Abstract

Rap2B, belonging to the Ras superfamily, has been implicated in cancer development and functions as a tumor promoter. However, the role of Rap2B in cervical cancer is unknown. In this study, we investigated the expression pattern and biological functions of Rap2B in cervical cancer. The results showed that Rap2B was overexpressed in cervical cancer tissues and cell lines. Knockdown of Rap2B inhibited the proliferation, migration, and invasion of cervical cancer cells. In addition, our tumorigenesis assay showed that Rap2B knockdown suppressed cervical cancer cell growth and metastasis in vivo. We also found that the ERK1/2 signaling pathway is involved in the inhibitory effect of Rap2B knockdown on cervical cancer development. In conclusion, we suggest that Rap2B is an oncogene and may be a promising therapeutic target for cervical cancer.

Publisher

Cognizant, LLC

Subject

Cancer Research,Oncology,General Medicine

Reference31 articles.

1. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008;Int J Cancer,2010

2. Radiotherapy versus radiochemotherapy with cisplatin in treatment of cervical cancer;Med Oncol.,2010

3. Risk factors for cervical cancer in rural areas of Wuhan China: A matched case-control study;Asian Pac J Cancer Prev.,2013

4. [Epidemiology and risk factors for cancer of the uterus];La Revue Du Praticien,2014

5. Modern treatment of invasive carcinoma of the uterine cervix;J BUON,2009

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3